Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × Therapeutics × 1 year × Clear all

Sponsor

Conditions

Neoplasms 9 Depression 7 Breast Neoplasms 7 Prostatic Neoplasms 6 Neoplasm Metastasis 5 Lymphoma, Follicular 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Anxiety Disorders 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Myeloproliferative Disorders 2 Multiple Myeloma 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Head and Neck Neoplasms 2 Fatigue 2 Colorectal Neoplasms 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Unresectable Hepatocellular Carcinoma 1 Thrombocythemia, Essential 1 Substance-Related Disorders 1

Interventions

Carboplatin 8 pembrolizumab 6 Radiotherapy 5 Pemetrexed 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Radiation 4 Paclitaxel 3 Nivolumab 3 Cisplatin 3 Biopsy 3 fludarabine phosphate 2 durvalumab 2 aldesleukin 2 Taxes 2 Radiotherapy, Conformal 2 Platinum 2 Ipilimumab 2 Interleukin-2 2 Immunoglobulin G 2 Disulfides 2 Cyclophosphamide 2 CTLA-4 Antigen 2 Bevacizumab 2 1,2-diaminocyclohexaneplatinum II citrate 2 veliparib 1 trametinib 1 sotorasib 1 rucaparib 1 ribociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡